{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:53:53Z","timestamp":1788303233585,"version":"build-2803163510"},"reference-count":135,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Intensive Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jointm.2023.09.006","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T20:33:33Z","timestamp":1703018013000},"page":"160-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Latest developments in early diagnosis and specific treatment of severe influenza infection"],"prefix":"10.1016","volume":"4","author":[{"given":"Francisco","family":"Valenzuela-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Valenzuela-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Rodr\u00edguez-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Estella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jointm.2023.09.006_bib0001","unstructured":"Influenza (Seasonal). [Internet]. Who.int. 2019 [Access: November 9, 2023]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.epidem.2011.02.001","article-title":"Geography may explain adult mortality from the 1918-20 influenza pandemic","volume":"3","author":"Mamelund","year":"2011","journal-title":"Epidemics"},{"issue":"7","key":"10.1016\/j.jointm.2023.09.006_bib0003","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/aje\/kwz044","article-title":"Re: \"reassessing the global mortality burden of the 1918 influenza pandemic","volume":"188","author":"Chandra","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc8183","article-title":"Clinical review: primary influenza viral pneumonia","volume":"13","author":"Rello","year":"2009","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0005","first-page":"177","article-title":"CRIPS investigators. influenza infection in the intensive care unit: four years after the 2009 pandemic","volume":"34","author":"P\u00e9rez-Carrasco","year":"2016","journal-title":"EnfermInfeccMicrobiol Clin"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0006","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1073\/pnas.73.6.2142","article-title":"Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes","volume":"73","author":"Palese","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0007","doi-asserted-by":"crossref","first-page":"397","DOI":"10.18388\/abp.2014_1857","article-title":"Introduction to molecular biology of influenza a viruses","volume":"61","author":"Szewczyk","year":"2014","journal-title":"Acta Biochim Pol"},{"issue":"9","key":"10.1016\/j.jointm.2023.09.006_bib0008","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1073\/pnas.73.9.3045","article-title":"Influenza virus genome consists of eight distinct RNA species","volume":"73","author":"McGeoch","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0009","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0042-6822(69)90132-9","article-title":"Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus","volume":"38","author":"Laver","year":"1969","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.jointm.2023.09.006_bib0010","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3892\/etm.2016.3636","article-title":"Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus","volume":"12","author":"Wang","year":"2016","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biologicals.2009.02.012","article-title":"An overview of influenza hemagglutinin and neuraminidase","volume":"37","author":"Skehel","year":"2009","journal-title":"Biologicals"},{"issue":"Pt 4","key":"10.1016\/j.jointm.2023.09.006_bib0012","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1099\/0022-1317-83-4-723","article-title":"The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication","volume":"83","author":"Portela","year":"2002","journal-title":"J Gen Virol"},{"issue":"20","key":"10.1016\/j.jointm.2023.09.006_bib0013","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jointm.2023.09.006_bib0014","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4161\/viru.21864","article-title":"Dendritic cells and influenza A virus infection","volume":"3","author":"Waithman","year":"2012","journal-title":"Virulence"},{"issue":"11","key":"10.1016\/j.jointm.2023.09.006_bib0015","doi-asserted-by":"crossref","first-page":"e28063","DOI":"10.1371\/journal.pone.0028063","article-title":"Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination","volume":"6","author":"Wagar","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0016","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13054-019-2539-x","article-title":"Influenza virus-related critical illness: pathophysiology and epidemiology","volume":"23","author":"Kalil","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jointm.2023.09.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3146065","article-title":"Innate immune and inflammatory responses to respiratory viruses","volume":"2019","author":"Li","year":"2019","journal-title":"Mediators Inflamm"},{"issue":"12","key":"10.1016\/j.jointm.2023.09.006_bib0018","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","article-title":"Current gaps in sepsis immunology: new opportunities for translational research","volume":"19","author":"Rubio","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S2213-2600(17)30005-X","article-title":"Theranostics in severe influenza","volume":"5","author":"Rello","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jointm.2023.09.006_bib0020","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3389\/fimmu.2018.02147","article-title":"Epidemiology and immune pathogenesis of viral sepsis","volume":"9","author":"Lin","year":"2018","journal-title":"Front Immunol"},{"issue":"49","key":"10.1016\/j.jointm.2023.09.006_bib0021","doi-asserted-by":"crossref","first-page":"e32245","DOI":"10.1097\/MD.0000000000032245","article-title":"Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients","volume":"101","author":"Raymond","year":"2022","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.jointm.2023.09.006_bib0022","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.idc.2017.07.005","article-title":"Influenza in older adults","volume":"31","author":"Talbot","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.jointm.2023.09.006_bib0023","first-page":"e12007","article-title":"Influenza myocarditis: a literature review","volume":"12","author":"Baral","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jointm.2023.09.006_bib0024","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00008210","article-title":"Right and left heart failure in severe H1N1 influenza A infection","volume":"37","author":"Brown","year":"2011","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jointm.2023.09.006_bib0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/irv.12470","article-title":"The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection","volume":"11","author":"Sellers","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jointm.2023.09.006_bib0026","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/367623","article-title":"Acute encephalopathy associated with influenza A virus infection","volume":"36","author":"Steininger","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.jointm.2023.09.006_bib0027","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/QAD.0b013e32833e508f","article-title":"Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study","volume":"24","author":"Riera","year":"2010","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jpm12010084","article-title":"Plasma levels of mid-regional proadrenomedullin accurately identify H1N1pdm09 influenza virus patients with risk of intensive care admission and mortality in the emergency department","volume":"12","author":"Valenzuela-M\u00e9ndez","year":"2022","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccc.2017.08.007","article-title":"Management of sepsis-induced immunosuppression","volume":"34","author":"Venet","year":"2018","journal-title":"Crit Care Clin"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0030","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jointm.2023.09.006_bib0031","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cyto.2017.01.012","article-title":"Immunoparalysis: clinical and immunological associations in SIRS and severe sepsis patients","volume":"92","author":"Papadopoulos","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jointm.2023.09.006_bib0032","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/01.CCM.0000275271.77350.B6","article-title":"Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock","volume":"35","author":"Venet","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jointm.2023.09.006_bib0033","doi-asserted-by":"crossref","first-page":"e92823","DOI":"10.1371\/journal.pone.0092823","article-title":"Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells","volume":"9","author":"Diao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jointm.2023.09.006_bib0034","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2022.07.010","article-title":"Host response dysregulations amongst adults hospitalized by influenza A H1N1 virus pneumonia: a prospective multicenter cohort study","volume":"104","author":"Valenzuela-M\u00e9ndez","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.jointm.2023.09.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2018.03.011","article-title":"Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases","volume":"24","author":"Rello","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jointm.2023.09.006_bib0036","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1128\/IAI.00298-15","article-title":"Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease","volume":"83","author":"Rynda-Apple","year":"2015","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.jointm.2023.09.006_bib0037","first-page":"693","article-title":"An\u00e1lisis de las coinfeccionesdetectadas entre los virus gripales A y B y otros virus respiratorios, 2012-2013 [Analysis of co-infections between influenza A and influenza B viruses and other respiratory viruses, 2012-2013] (in Spanish)","volume":"32","author":"Reina","year":"2014","journal-title":"EnfermInfeccMicrobiol Clin"},{"issue":"Suppl 2","key":"10.1016\/j.jointm.2023.09.006_bib0038","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/irv.12089","article-title":"Bacterial and viral infections associated with influenza","volume":"7","author":"Joseph","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"10.1016\/j.jointm.2023.09.006_bib0039","first-page":"449","article-title":"Severe influenza: overview in critically ill patients","volume":"25","author":"Sarda","year":"2019","journal-title":"CurrOpin Crit Care"},{"issue":"9","key":"10.1016\/j.jointm.2023.09.006_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.02.013","article-title":"Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production","volume":"30","author":"Sencio","year":"2020","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0041","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00134-009-1746-3","article-title":"Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection","volume":"36","author":"Ingram","year":"2010","journal-title":"Intensive Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.jointm.2023.09.006_bib0042","doi-asserted-by":"crossref","first-page":"A832","DOI":"10.1186\/2197-425X-3-S1-A832","article-title":"Initial levels of mr-proadrenomedullin: a predictor of severity in patients with influenza a virus pneumonia","volume":"3","author":"Valenzuela-Sanchez","year":"2015","journal-title":"Intensive Care Med Exp"},{"issue":"5","key":"10.1016\/j.jointm.2023.09.006_bib0043","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00134-011-2189-1","article-title":"Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? a multicentre study","volume":"37","author":"Cuquemelle","year":"2011","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0044","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/cc13760","article-title":"Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis","volume":"18","author":"Pfister","year":"2014","journal-title":"Crit Care"},{"issue":"17","key":"10.1016\/j.jointm.2023.09.006_bib0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.21037\/atm.2016.08.65","article-title":"New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure","volume":"4","author":"Valenzuela-S\u00e1nchez","year":"2016","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0046","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jemt.10052","article-title":"Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions","volume":"57","author":"Kitamura","year":"2002","journal-title":"Microsc Res Tech"},{"issue":"4","key":"10.1016\/j.jointm.2023.09.006_bib0047","doi-asserted-by":"crossref","first-page":"366","DOI":"10.23736\/S0375-9393.18.12687-3","article-title":"Plasma levels of mid-regional pro-adrenomedullin in sepsis are associated with risk of death","volume":"85","author":"Valenzuela-S\u00e1nchez","year":"2019","journal-title":"Minerva Anestesiol"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0048","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/healthcare6030110","article-title":"Mid-regional pro-adrenomedullin (MR-proADM) as a biomarker for sepsis and septic shock: narrative review","volume":"6","author":"\u00d6nal","year":"2018","journal-title":"Healthcare"},{"issue":"10","key":"10.1016\/j.jointm.2023.09.006_bib0049","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.23736\/S0375-9393.21.15585-3","article-title":"The diagnostic accuracy of mid-regional pro-adrenomedullin for sepsis: a systematic review and meta-analysis","volume":"87","author":"Li","year":"2021","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13613-017-0238-9","article-title":"Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity","volume":"7","author":"Andaluz-Ojeda","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0051","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13054-018-2001-5","article-title":"The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial","volume":"22","author":"Elke","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.jointm.2023.09.006_bib0052","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijid.2021.08.058","article-title":"Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients","volume":"111","author":"Garc\u00eda de Guadiana-Romualdo","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jointm.2023.09.006_bib0053","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcrc.2021.07.017","article-title":"Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: a prospective cohort study","volume":"66","author":"van Oers","year":"2021","journal-title":"J Crit Care"},{"issue":"15","key":"10.1016\/j.jointm.2023.09.006_bib0054","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.3390\/jcm11154543","article-title":"Proadrenomedullin in the management of COVID-19 critically ill patients in intensive care unit: a systematic review and meta-analysis of evidence and uncertainties in existing literature","volume":"11","author":"Montrucchio","year":"2022","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"10.1016\/j.jointm.2023.09.006_bib0055","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0056","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00134-019-05868-8","article-title":"Severe flu management: a point of view","volume":"46","author":"Torres","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jointm.2023.09.006_bib0057","unstructured":"European Centre for Disease Prevention and Control. An agency of the European Union (2019) Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza\u2014review of recent systematic reviews and meta-analyses. 2019. https:\/\/www.ecdc.europa.eu\/en\/seasonal-influenza\/prevention-and-control\/antivirals\/neuraminidase-inhibitors."},{"issue":"11","key":"10.1016\/j.jointm.2023.09.006_bib0058","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s00134-010-2009-z","article-title":"Bronchoalveolar lavage for pandemic influenza A (H1N1)v pneumonia in critically ill patients","volume":"36","author":"Estella","year":"2010","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0059","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/SHK.0000000000001023","article-title":"Procalcitonin and MR-proadrenomedullin combination with SOFA and qSOFA scores for sepsis diagnosis and prognosis: a diagnostic algorithm","volume":"50","author":"Spoto","year":"2018","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/CCM.0b013e318194b021","article-title":"PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia","volume":"37","author":"Rello","year":"2009","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0061","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12916-022-02616-6","article-title":"Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines","volume":"20","author":"Rigby","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.jointm.2023.09.006_bib0062","unstructured":"Global Preparedness Monitoring Board. A world at risk: GPMB 2019 annual report. A world at risk: GPMB 2019 annual report. https:\/\/www.gpmb.org\/annual-reports\/annual-report-2019. [Last accessed on2023 April 15]."},{"issue":"39","key":"10.1016\/j.jointm.2023.09.006_bib0063","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1016\/j.vaccine.2018.07.028","article-title":"Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015","volume":"36","author":"Thompson","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jointm.2023.09.006_bib0064","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.3390\/ijerph19053018","article-title":"Antiviral drugs in influenza","volume":"19","author":"\u015awierczy\u0144ska","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jointm.2023.09.006_bib0065","unstructured":"EMA, Tamiflu. Summary of product characteristic. Available From: https:\/\/www.ema.europa.eu\/en\/documents\/productinformation\/tamiflu-epar-productinformation_en.pdf [Last accessed on2023 April 15]."},{"key":"10.1016\/j.jointm.2023.09.006_bib0066","series-title":"Guidelines for the clinical management of severe illness from influenza virus infections","year":"2022"},{"issue":"5","key":"10.1016\/j.jointm.2023.09.006_bib0067","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.jointm.2023.09.006_bib0068","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1473-3099(17)30476-0","article-title":"Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Beigel","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jointm.2023.09.006_bib0069","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","volume":"2014","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jointm.2023.09.006_bib0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/j.semperi.2014.08.015","article-title":"Oseltamivir for influenza in pregnancy","volume":"38","author":"Beigi","year":"2014","journal-title":"Semin Perinatol"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0071","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QCO.0000000000000498","article-title":"Neuraminidase inhibitor resistance in influenza: a clinical perspective","volume":"31","author":"Lee","year":"2018","journal-title":"CurrOpin Infect Dis"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0072","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/650581","article-title":"Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection","volume":"50","author":"To","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0073","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cnur.2019.02.009","article-title":"Seasonal influenza (Flu)","volume":"54","author":"Keilman","year":"2019","journal-title":"Nurs Clin North Am"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0074","doi-asserted-by":"crossref","first-page":"ofx129","DOI":"10.1093\/ofid\/ofx129","article-title":"Efficacy and safety of intravenous peramivir compared with oseltamivir in high-risk patients infected with influenza A and B viruses: a multicenter randomized controlled study","volume":"4","author":"Nakamura","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jointm.2023.09.006_bib0075","unstructured":"E.M.A. Alpivab,Withdrawal marketing authorisation in the European Union. Available From: https:\/\/www.ema.europa.eu\/en\/documents\/public-statement\/public-statement-alpivab-withdrawalmarketing-authorisation-european-union_en.pdf. [Last accessed on 2023 April 13]."},{"issue":"13","key":"10.1016\/j.jointm.2023.09.006_bib0076","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s40265-018-0981-8","article-title":"Peramivir: a review in uncomplicated influenza","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jointm.2023.09.006_bib0077","unstructured":"FDA. Rapivab, prescribing information. Available From: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/206426lbl.pdf. [Last accessed on 2023 April 15]."},{"issue":"10","key":"10.1016\/j.jointm.2023.09.006_bib0078","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/eri.11.112","article-title":"Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza","volume":"9","author":"Ikematsu","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"27","key":"10.1016\/j.jointm.2023.09.006_bib0079","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1021\/jp800171m","article-title":"A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine","volume":"112","author":"Yi","year":"2008","journal-title":"J Phys Chem B"},{"issue":"50","key":"10.1016\/j.jointm.2023.09.006_bib0080","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1021\/bi9014488","article-title":"Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus","volume":"48","author":"Balannik","year":"2009","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0081","article-title":"Amantadine and rimantadine for influenza A in adults","author":"Jefferson","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jointm.2023.09.006_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105035","article-title":"Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir","volume":"188","author":"Patel","year":"2021","journal-title":"Antiviral Res"},{"issue":"15","key":"10.1016\/j.jointm.2023.09.006_bib0083","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0084","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"CurrOpin Infect Dis"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0085","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jointm.2023.09.006_bib0086","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01432-20","article-title":"Discovery of a novel specific inhibitor targeting influenza A virus nucleoprotein with pleiotropic inhibitory effects on various steps of the viral life cycle","volume":"95","author":"Yang","year":"2021","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0087","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13054-015-0983-9","article-title":"Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice","volume":"19","author":"Nosaka","year":"2015","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.jointm.2023.09.006_bib0088","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/15321819.2018.1515775","article-title":"A brief review of monoclonal antibody technology and its representative applications in immunoassays","volume":"39","author":"Gao","year":"2018","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.jointm.2023.09.006_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104562","article-title":"New antibody-based prevention and treatment options for influenza","volume":"170","author":"Sedeyn","year":"2019","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1016\/j.jointm.2023.09.006_bib0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies","volume":"167","author":"Carrat","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jointm.2023.09.006_bib0091","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2019.04.006","article-title":"Advances in respiratory virus therapeutics - a meeting report from the 6th isirv Antiviral Group conference","volume":"167","author":"Beigel","year":"2019","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0092","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40262-017-0564-y","article-title":"Pharmacokinetics of MHAA4549A, an anti-influenza A monoclonal antibody, in healthy subjects challenged with influenza A virus in a phase II a randomized trial","volume":"57","author":"Deng","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jointm.2023.09.006_bib0093","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mai.2001.116576","article-title":"Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys","volume":"108","author":"Hart","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jointm.2023.09.006_bib0094","first-page":"148","article-title":"Development of plant-made monoclonal antibodies against viral infections","volume":"52","author":"Chen","year":"2022","journal-title":"CurrOpinVirol"},{"key":"10.1016\/j.jointm.2023.09.006_bib0095","article-title":"Broad neutralizing antibody-based strategies to tackle influenza","volume":"53","author":"Sun","year":"2022","journal-title":"CurrOpinVirol"},{"key":"10.1016\/j.jointm.2023.09.006_bib0096","article-title":"Editorial overview: anti-viral strategies: human antibody immune response and antibody-based therapy against viruses","volume":"55","author":"Wang","year":"2022","journal-title":"CurrOpinVirol"},{"issue":"21","key":"10.1016\/j.jointm.2023.09.006_bib0097","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0098","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","article-title":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","volume":"23","author":"Ni","year":"2019","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0099","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10096-016-2611-2","article-title":"Personalized medicine in severe influenza","volume":"35","author":"Valenzuela-S\u00e1nchez","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jointm.2023.09.006_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jinf.2015.11.007","article-title":"Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis","volume":"72","author":"Rodr\u00edguez","year":"2016","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jointm.2023.09.006_bib0101","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis","volume":"10","author":"Klein","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"issue":"12","key":"10.1016\/j.jointm.2023.09.006_bib0102","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1002\/jmv.26329","article-title":"Aggravated MRSA pneumonia secondary to influenza A virus infection is derived from decreased expression of IL-1\u03b2","volume":"92","author":"Shi","year":"2020","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.jointm.2023.09.006_bib0103","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0104","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.jointm.2023.09.006_bib0105","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/jof9030312","article-title":"Managing the next wave of influenza and\/or SARS-CoV-2 in the ICU-practical recommendations from an Expert Group for CAPA\/IAPA patients","volume":"9","author":"Peral","year":"2023","journal-title":"J Fungi"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1469-0691.2001.00187.x","article-title":"Therapy of ventilator-associated pneumonia: the Tarragona strategy","volume":"7","author":"Bod\u00ed","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jointm.2023.09.006_bib0107","series-title":"Guidelines for the clinical management of severe illness from influenza virus infections","year":"2022"},{"issue":"134","key":"10.1016\/j.jointm.2023.09.006_bib0108","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1183\/09059180.00009413","article-title":"International NIV network. Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review","volume":"23","author":"Esquinas","year":"2014","journal-title":"Eur Respir Rev"},{"issue":"11","key":"10.1016\/j.jointm.2023.09.006_bib0109","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","article-title":"An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy","volume":"199","author":"Roca","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jointm.2023.09.006_bib0110","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00134-020-06228-7","article-title":"Use of nasal high flow oxygen during acute respiratory failure","volume":"46","author":"Ricard","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jointm.2023.09.006_bib0111","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcrc.2021.08.012","article-title":"ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis","volume":"66","author":"Prakash","year":"2021","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0112","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13054-023-04567-7","article-title":"Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis","volume":"27","author":"Yau","year":"2023","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jointm.2023.09.006_bib0113","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jcrc.2012.04.006","article-title":"High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A\/H1N1v","volume":"27","author":"Rello","year":"2012","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12890-022-01833-2","article-title":"Flu-IV score: a predictive tool for assessing the risk of invasive mechanical ventilation in patients with influenza-related pneumonia","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CCM.0b013e31822d7938","article-title":"Corticosteroid after etomidate in critically ill patients: a randomized controlled trial","volume":"40","author":"Payen","year":"2012","journal-title":"Crit Care Med"},{"issue":"18","key":"10.1016\/j.jointm.2023.09.006_bib0116","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Network","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jointm.2023.09.006_bib0117","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13063-015-0759-1","article-title":"PReVENT \u2013 protective ventilation in patients without ARDS at start of ventilation: study protocol for a randomized controlled trial","volume":"16","author":"Simonis","year":"2015","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.jointm.2023.09.006_bib0118","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00134-015-3692-6","article-title":"Asynchronies during mechanical ventilation are associated with mortality","volume":"41","author":"Blanch","year":"2015","journal-title":"Intensive Care Med"},{"issue":"23","key":"10.1016\/j.jointm.2023.09.006_bib0119","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Gu\u00e9rin","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13054-023-04417-6","article-title":"Tracheostomy timing and outcome in critically ill patients with stroke: a meta-analysis and meta-regression","volume":"27","author":"Premraj","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0121","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13054-023-04443-4","article-title":"Early versus late tracheostomy: what do patients want?","volume":"27","author":"Sutt","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0122","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0971-9784.197820","article-title":"Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: a systematic review and meta-analysis","volume":"20","author":"Sukhal","year":"2017","journal-title":"Ann Card Anaesth"},{"issue":"1","key":"10.1016\/j.jointm.2023.09.006_bib0123","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccc.2017.08.003","article-title":"Mechanisms of organ dysfunction in sepsis","volume":"34","author":"Pool","year":"2018","journal-title":"Crit Care Clin"},{"issue":"10","key":"10.1016\/j.jointm.2023.09.006_bib0124","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00134-016-4416-2","article-title":"Is the macrocirculation really dissociated from the microcirculation in septic shock?","volume":"42","author":"Hern\u00e1ndez","year":"2016","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0125","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1164\/ajrccm.161.6.9812004","article-title":"Effects of nitric oxide in septic shock","volume":"161","author":"Vincent","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"10.1016\/j.jointm.2023.09.006_bib0126","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jointm.2023.09.006_bib0127","series-title":"Functional hemodynamic monitoring","first-page":"99","article-title":"Central venous pressure: uses and limitations","author":"Smith","year":"2006"},{"issue":"11","key":"10.1016\/j.jointm.2023.09.006_bib0128","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s12325-017-0622-8","article-title":"Sepsis: a review of advances in management","volume":"34","author":"Rello","year":"2017","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0129","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00134-010-1843-3","article-title":"Effects of fluids on microvascular perfusion in patients with severe sepsis","volume":"36","author":"Ospina-Tascon","year":"2010","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.jointm.2023.09.006_bib0130","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1365-2044.1991.tb09922.x","article-title":"Continuous direct and indirect blood pressure measurement (Finapres) in the critically ill","volume":"46","author":"Farquhar","year":"1991","journal-title":"Anaesthesia"},{"issue":"6","key":"10.1016\/j.jointm.2023.09.006_bib0131","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SHK.0000000000000064","article-title":"Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy","volume":"40","author":"Kim","year":"2013","journal-title":"Shock"},{"issue":"19","key":"10.1016\/j.jointm.2023.09.006_bib0132","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-014-0734-3","article-title":"Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial","volume":"8","author":"Richard","year":"2015","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.jointm.2023.09.006_bib0133","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00134-005-2731-0","article-title":"Esophageal Doppler monitoring predicts fluid responsiveness in critically ill ventilated patients","volume":"31","author":"Monnet","year":"2005","journal-title":"Intensive Care Med"},{"issue":"21","key":"10.1016\/j.jointm.2023.09.006_bib0134","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1056\/NEJMoa061895","article-title":"Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury","volume":"354","author":"Wheeler","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jointm.2023.09.006_bib0135","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"}],"container-title":["Journal of Intensive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X23000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X23000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T19:32:11Z","timestamp":1714591931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667100X23000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2667100X23000877"],"URL":"https:\/\/doi.org\/10.1016\/j.jointm.2023.09.006","relation":{},"ISSN":["2667-100X"],"issn-type":[{"value":"2667-100X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latest developments in early diagnosis and specific treatment of severe influenza infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Intensive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jointm.2023.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}